Skip to main content
OpenTrials
Completed

NCT Number: NCT04767139

EPI, a Missed Opportunity for Postpartum Family Planning Utilization

The global unmet need for postpartum family planning remains high, while immunization services are among the most widely utilized health services. Most women in the extended postpartum period want to delay or avoid future pregnancies but many are not using a modern contraceptive method. Establishing systematic screening, counseling, and referral systems from different contact points particularly from infant immunization units may improve family planning access and uptake in the extended postpartum period. Hence, this study is aimed to assess the effect of counseling for family planning at immunization units on postpartum contraceptive uptake during the extended postpartum period.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

15 year–49 year

Sex eligibility

Female

Study type

Observational

Primary location

Sidama regional health bureau

Awasa, Sidama Region, Ethiopia

About this study

Background: The global unmet need for postpartum family planning remains high, while immunization services are among the most widely utilized health services. Most women in the extended postpartum period want to delay or avoid future pregnancies but many are not using a modern contraceptive method. Establishing systematic screening, counseling, and referral systems from different contact points particularly from Expanded Program for Immunization (EPI) units may improve family planning access and uptake in the extended perinatal period.

Therefore, this study is proposed to assess the effect of counseling for family planning at immunization units on postpartum contraceptive uptake during the extended postpartum period.

To do this, a before-and-after type of quasi-experimental study will be conducted in purposively selected health centers in Sidama, South Ethiopia. All mothers coming to the selected health centers for infant immunization services will be screened for, counseled, and referred for family planning. A structured interviewer-administered questionnaire will be used to collect quantitative data from a total of 1474 randomly selected women coming to purposively selected health centers before and after the intervention. Bivariate and multivariable logistic regression analysis adjusting for possible confounding variables will be computed.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all women visiting the selected health facilities at least two times during the pre-intervention period will be included

Exclusion criteria

  • No exclussion critera

Treatment and study plan

counseling for family planning

Behavioral

all mothers presented to infant immunization units of the selected health centers will be counseled for family planning service and referred to the family planning unit if they decided to use.

Primary outcomes

  1. improved contraceptive uptake

    Time frame: March 3, 2021

    the contraceptive utilization rate will be increased after the initiation of the intervention

Sponsors and collaborators

Lead sponsor

Hawassa University

Other

Collaborators

  • EngenderHealth

Registry information

Official study title

Expanded Program for Immunization, a Missed Opportunity for Postpartum Family Planning Utilization: A Quasi Experimental Study

Acronym: EPI

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Feb 23, 2021
Registry last updated
Mar 3, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.